![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, September 23, 2014 8:20:24 PM
Jafar Mahmoudian
Current position
•
2006 to date, Research Associate, Immunochemistry department, Monoclonal
Antibody Research Center, Avicenna Research Institute.
Advisor: Dr. Mahmoud Jeddi-Tehrani
(E-mail: mahjed@yahoo.com)
Current activity
•
Cancer Immunotherapy
Currently, one of our main interests is trying to acquire specific vaccines for various cancers in collaboration with Karolinska institute. Owing to side-effects traits of famous antibodies like Herceptin antibody; we are going to find alternative ones.
http://www.avicenna.ac.ir/Documents/CV/mahmoudian.pdf
Ok.... digging deeper, we have Advisor: Dr. Mahmoud Jeddi-Tehrani, tied directly into Peregrine KOL Hakan Mellstedt:
If you look at the publications... Hakan Mellstedt is all over the place with Dr Mahmoud Jeddi-Tehrani, and Dr. Jeddi-Tehrani has roots back in Karolinska, home of Hakan Mellstedt
Administration
. Head of diagnostic lab of Iran University of medical science.
. Head of Department of Immunology, Avesina Research Center.
. Head of Monoclonal Antibody Research Center.
. Member of Medical Biotechnology board of Iran.
http://www.avicenna.ac.ir/Documents/CV/tehrani.pdf
Is that enough to clearly show that Peregrine has some form of direct/indirect collaborations, stem cell research/vaccines..etc ?
Well that first profile above: Jafar Mahmoudian
5.Production of Monoclonal Antibody against Human Nestin
Reza Hadavi , Amir Hassan Zarnani , Negah Ahmadvand , Ahmad Reza Mahmoudi ,Ali Ahmad Bayat, Jafar Mahmoudian, Mohammad Reza Sadeghi , Haleh Soltanghoraee , Mohammad Mehdi Akhondi, Majid Tarahomi , Mahmood Jeddi-Tehrani , Hodjattallah Rabbani, Avicenna Journal of Medical Biotechnology, Vol. 2, Issue 2 (2010), 69 - 77
http://www.avicenna.ac.ir/Documents/CV/mahmoudian.pdf
well... it looks like I possibly found the connections to the many "followers" of Peregrine from this region of the world, which was puzzling for a bit, but its interesting how many follow very few Big Pharma... but decide to track Peregrine
Everyone follows and tracks for a reason, even everyone on this board. What a wonderful puzzle we have here... : )
Keep Calm and May the (Jeddi) Force Be With You....
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
Recent CDMO News
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/19/2023 09:05:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:34:08 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM